| Filed On | Filing |
|---|---|
| 04 Jan 2023 |
8-K/A: Submission of Matters to a Vote of Security Holders
The non-binding, advisory vote regarding the frequency of voting on the compensation paid to the Company's named executive officers was in favor of voting every one year: |
| 04 Nov 2022 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On June 27, 2022, Mesa Laboratories, Inc. (“Mesa” or the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) disclosing that the Board of Directors (the “Board”) of Mesa had expanded the size of its Board from seven to eigh... |
| 22 Dec 2021 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated financial statements of Agena Bioscience, Inc., which comprise the consolidated balance sheets as of December 31, 2020 and 2019, and the related consolidated statements of operations and comp... |
| 15 Jan 2020 |
8-K/A: Financial Statements and Exhibits
for the financial years January 1 – December 31 2018 and 2017 |
| 05 Aug 2019 | 8-K/A: Other Events |
| 06 Nov 2018 |
8-K/A: Submission of Matters to a Vote of Security Holders
The Annual Meeting of Shareholders of Mesa Laboratories, Inc. was held on October 30, 2018. Of the 3,850,775 shares of common stock entitled to vote, 3,485,171 were represented either in person or proxy. Eight directors were elected to s... |
| 27 Jul 2012 |
8-K/A: Financial Statements and Exhibits
As used in this report, we, us, our, Mesa or Company refer to Mesa Laboratories, Inc. The unaudited pro forma condensed combined financial statements present the impact on our financial position and results of operations from our asset a... |
| 29 Jul 2010 |
8-K/A: Financial Statements and Exhibits
The following unaudited pro forma combined balance sheet as of March 31, 2010 and the unaudited pro forma combined statement of operations for the year ended March 31, 2010 give effect to Mesa Laboratories, Inc.’s (“Mesa”) acquisition of... |
| 13 Jul 2010 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated balance sheets of SGM Biotech, Inc. and Affiliate (the “Company”) as of December 31, 2009 and 2008, and the related consolidated statements of income, changes in stockholders’ and members’ eq... |
| 20 Jul 2006 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying balance sheet of Raven Biological Laboratories, Inc. as of October 31, 2005, and the related statements of income, changes in stockholders’ equity and cash flows for the year then ended. These financial s... |
Loading...